Brian Blakey
Corporate Officer/Principal bei STEALTH BIOTHERAPEUTICS CORP
Profil
Brian D.
Blakey is currently the Chief Business Officer at Stealth BioTherapeutics Corp.
and Stealth BioTherapeutics, Inc. He previously worked as a Director at GSK Plc from 1998 to 2004, as Vice President-Marketing at AtheroGenics, Inc. from 2006 to 2010, and as Chief Operations & Strategy Officer at Ogilvy Commonhealth Market Access from 2010 to 2014.
He received a doctorate degree from the University of Florida in 1986.
Aktive Positionen von Brian Blakey
| Unternehmen | Position | Beginn |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Corporate Officer/Principal | 01.02.2014 |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Corporate Officer/Principal | 01.02.2014 |
Ehemalige bekannte Positionen von Brian Blakey
| Unternehmen | Position | Ende |
|---|---|---|
Ogilvy Commonhealth Market Access
 Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Part of WPP Plc, Ogilvy Commonhealth Market Access is a company that provides medical marketing services. The company is based in Newtown, CT. Ogilvy Commonhealth Market Access was acquired by Ogilvy Commonhealth Worldwide LLC on October 07, 2014. | Geschäftsführer | 01.02.2014 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Corporate Officer/Principal | 01.05.2010 |
| GSK PLC | Direktor/Vorstandsmitglied | 01.02.2004 |
Ausbildung von Brian Blakey
| University of Florida | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Ogilvy Commonhealth Market Access
Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Part of WPP Plc, Ogilvy Commonhealth Market Access is a company that provides medical marketing services. The company is based in Newtown, CT. Ogilvy Commonhealth Market Access was acquired by Ogilvy Commonhealth Worldwide LLC on October 07, 2014. | Commercial Services |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA. | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Health Technology |
